Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 30, 2023

Actavis Group Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ACTAVIS GROUP, and what generic and branded alternatives to ACTAVIS GROUP drugs are available?

ACTAVIS GROUP has one approved drug.

Summary for Actavis Group

US Patents:	0
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Actavis Group

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-004	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-001	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-005	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-006	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-003	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Group	HALOPERIDOL	haloperidol	TABLET;ORAL	200854-002	Jul 1, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Baxter

McKesson

Merck

Johnson and Johnson

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.